Total plasma homocysteine and methylenetetrahydrofolate reductase C677T polymorphism in patients with colorectal carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 38

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

274

HTML

2200

Figures (1-2)

165

Tables (1-3)

125

Sum=2764

Oct 14, 2006 (publication date) through Apr 23, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Colorectal Cancer

World J Gastroenterol. Oct 14, 2006; 12(38): 6128-6132
Published online Oct 14, 2006. doi: 10.3748/wjg.v12.i38.6128

Figure 1 Mean tHcy plasma levels according to C677T MTHFR genotype, ^aP < 0. 04, ^bP < 0.01 vs control.

Figure 2 Mean tHcy plasma levels according to C677T MTHFR polymorphism, ^bP < 0. 002 vs control; NS: Not significant.

Citation: Battistelli S, Vittoria A, Stefanoni M, Bing C, Roviello F. Total plasma homocysteine and methylenetetrahydrofolate reductase C677T polymorphism in patients with colorectal carcinoma. World J Gastroenterol 2006; 12(38): 6128-6132
URL: https://www.wjgnet.com/1007-9327/full/v12/i38/6128.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i38.6128